Share this article
Share this article
BOSTON, Feb. 24, 2021 /PRNewswire/ Researchers at two major medical centers in Israel, Rambam Medical Health Care Campus and Ziv Medical Center, have initiated a Phase 2 clinical trial of a promising new treatment for COVID-19.
These trials are testing TXA27, a compound with an established safety profile. TXA127 has been developed by Boston-based Constant Therapeutics We are examining the use of a drug based on a naturally occurring peptide called Angiotensin (1-7), that prevents cell proliferation and inflammation in the lungs, said Professor Karl Skorecki, Dean of the Azrieli Faculty of Medicine of Bar-Ilan University in the Galilee.
FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
First Report on Mass Shootings from Columbia University Database
forensicmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forensicmag.com Daily Mail and Mail on Sunday newspapers.
KEY CONCEPTS
Ready or not, next week brings us the first day of March and the beginning of meteorological spring. In our analysis of 243 cities across the U.S., 120 cities (49%) have recorded an increase in average spring temperatures of 2℉ or more over the past fifty years. Further, 96% of cities (234) reported an increase in the number of above-normal spring days since 1970, with 81% of cities (196) reporting an increase of 5 days or more.
Warming spring temperatures follow a pattern of warmer seasons encroaching on the cold of winter resulting in an earlier advent of spring and throwing timing of natural events into misalignment. For instance, earlier snowmelt can result in changes in water availability and challenges to the breeding of native fish. Earlier spring temperatures can also lengthen the growing season, supporting longer pollen allergy seasons that start earlier and stick around for longer.